The demo reached each its Major endpoints, with semaglutide two.four mg demonstrating statistically important and excellent improvements in liver fibrosis without worsening of steatohepatitis, along with resolution of steatohepatitis with no worsening of liver fibrosis in people with MASH as compared to placebo.oneFantastic luck! System your foods